Development of gene therapy for blood disorders by gene transfer into haemotopoietic stem cells

Haemophilia

Volumn 8, Issue 3, 2002, Pages 255-260

  Karlsson, S ^a   Ooka, A ^a   Woods, N B ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Gene therapy; Gene transfer; Haematopoietic stem cell; Lentiviral vector

Indexed keywords

RETROVIRUS VECTOR;

ARTICLE; AUTOTRANSPLANTATION; BLOOD DISEASE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL DIVISION; CHROMOSOME; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; DNA MODIFICATION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; INTEGRATION; LENTIVIRINAE; NONHUMAN; PRIORITY JOURNAL; PROVIRUS; RECIPIENT; TARGET CELL; ANIMAL; CELL LINEAGE; CYTOLOGY; GENETICS; HEMATOPOIETIC STEM CELL; HEMOPHILIA A; HUMAN; METABOLISM; METHODOLOGY; REVIEW;

ANIMALS; CELL LINEAGE; GENE THERAPY; GENE TRANSFER TECHNIQUES; HEMATOPOIETIC STEM CELLS; HEMOPHILIA A; HUMANS; LENTIVIRUS;

EID: 0036588698     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2002.00470.x     Document Type: Article

References (28)

1. Richter J, Karlsson S. Clinical gene therapy in hematology: past and future. Int J Hematol 2001; 73: 162-9.
2. Woods N-B, Ooka A, Karlsson S. Development of gene therapy for hematopoietic stem cells using lentiviral vectors. Leukemia 2002; in press.
3. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000; 288: 669-72.
4. Cheshier SH, Morrison SJ, Liao X, Weissman IL. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc Natl Acad Sci USA 1999; 96: 3120-5.
5. Gothot A, van der Loo JC, Clapp DW, Srour EF. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice. Blood 1998; 92: 2641-9.
6. Miller DG, Adam MA, Miller AD. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 1990; 10: 4239-42.
7. Relander T, Brun A, Hawley RG, Karlsson S, Richter J. Retroviral transduction of human CD34+ cells on fibronectin fragment CH-296 is inhibited by high concentrations of vector containing medium. J Gene Med 2001; 3: 207-18.
8. 0. Blood 2000; 96: 4185-93.
9. Naldini L, Blomer U, Gallay P et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272: 263-7.
10. Dull T, Zufferey R, Kelly M et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998; 72: 8463-71.
11. Miyoshi H, Smith KA, Mosier DE, Verma IM, Torbett BE. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 1999; 283: 682-6.
12. Woods NB, Fahlman C, Mikkola H et al. Lentiviral gene transfer into primary and secondary NOD/SCID repopulating cells. Blood 2000; 96: 3725-33.
13. May C, Rivella S, Callegari J et al. Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin. Nature 2000; 406: 82-6.
14. Sirven A, Ravet E, Charneau P et al. Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors. Mol Ther 2001; 3: 438-48.
15. Klages N, Zufferey R, Trono D. A stable system for the high-titer production of multiply attenuated lentiviral vectors. Mol Ther 2000; 2: 170-6.
16. Sutton RE, Reitsma MJ, Uchida N, Brown PO. Transduction of human progenitor hematopoietic stem cells by human immunodeficiency virus type 1-based vectors is cell cycle dependent. J Virol 1999; 73: 3649-60.
17. Mikkola H, Woods NB, Sjogren M et al. Lentivirus gene transfer in murine hematopoietic progenitor cells is compromised by a delay in proviral integration and results in transduction mosaicism and heterogeneous gene expression in progeny cells. J Virol 2000; 74: 11911-8.
18. Salmon P, Kindler V, Ducrey O, Chapuis B, Zubler RH, Trono D. High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors. Blood 2000; 96: 3392-8.
19. Ramezani A, Hawley TS, Hawley RG. Lentiviral vectors for enhanced gene expression in human hematopoietic cells. Mol Ther 2000; 2: 458-69.
20. Hamaguchi I, Woods NB, Panagopoulos I et al. Lentivirus vector gene expression during ES cell-derived hematopoietic development in vitro. J Virol 2000; 74: 10778-84.
21. Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701-5.
22. Lagasse E, Connors H, Al-Dhalimy M et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000; 6: 1229-34.
23. Weissman IL. Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science 2000; 287: 1442-6.
24. Lagasse E, Shizuru JA, Uchida N, Tsukamoto A, Weissman IL. Toward regenerative medicine. Immunity 2001; 14: 425-36.
25. Anderson DJ, Gage FH, Weibssman IL. Can stem cells cross lineage boundaries? Nat Med 2001; 7: 393-5.
26. Jin L, Zeng H, Chien S et al. In vivo selection using a cell-growth switch. Nat Genet 2000; 26: 64-6.
27. Trono D. Lentiviral vectors: turning a deadly foe into a therapeutic agent. Gene Ther 2000; 7: 20-3.
28. Vassilopoulos G, Trobridge G, Josephson NC, Russell DW. Gene transfer into murine haematopoietic stem cells with helper-free foamy virus vectors. Blood 2001; 98: 604-9.